Prosecution Insights
Last updated: May 29, 2026

Roche Diagnostics Operations Inc.

43 pending office actions • 27 art units • 39 examiners • 0 of 43 (0%) have an AI response strategy ready • 66 patents granted in the last 365 days

Portfolio Summary

43
Total Pending OAs
29
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 43 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

19
Overdue
0
Due this week
14
Due this month
8
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 43 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (19)Due ≤ 30 days (14)Due ≤ 60 days (8)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (14%)
31
Medium (72%)
5
Easy (12%)
1
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only6 (14%)
§103 only24 (56%)
§102 only6 (14%)
§112 only5 (12%)
Double-patenting + other1 (2%)
No statute on record1 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

32
Life Sciences
74% of docket
1
Information Tech
2% of docket
0
Communications
0% of docket
2
Semiconductors
5% of docket
8
Mechanical / Eng
19% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

430 h
Manual time on pending OAs
86 h
Time saved (low, 20%)
150 h
Time saved (mid, 35%)
3.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COUNTS, GARY W 3 58.9% +29.3%
MARCSISIN, ELLEN JEAN 2 32.8% +48.6%
NGUYEN, NAM P 2 54.7% +46.4%
JORGENSEN, ABBY A 1 73.6% +16.7%
SANGHERA, STEVEN G.S. 1 30.4% +29.4%
DOWNING, SAVANNAH STARR 1 75.7% +5.9%
WAQAS, SAAD A 1 73.4% +39.9%
HAUK TEODORO, PRICILA NMN 1 100.0% +0.0%
BROTHERS, LAURENCE RAPHAEL 1 87.1% +17.8%
MOAZZAMI, NAGHMEH NINA 1 71.7% +42.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18560126 METHOD FOR OPERATING A LABORATORY AUTOMATION SYSTEM, LABORATORY AUTOMATION SYSTEM, AND LABORATORY IN-VITRO DIAGNOSTIC SYSTEM BROTHERS, LAURENCE RAPHAEL 12d
18542054 THERMOSTABLE AFFINITY POLYPEPTIDES HAUK TEODORO, PRICILA NMN 57d

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17575120 S100A9 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS IVICH, FERNANDO NMN 19d overdue
18149810 METHOD AND LABORATORY SYSTEM TO PROVIDE CONTROL SAMPLES FOR VALIDATING A DIAGNOSTICS TEST MCGUIRK, JOHN SCHUYLER 8d overdue
17575202 S100A12 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS MONTGOMERY, ANN Y 28d
17772959 SEPSIS MANAGEMENT COUNTS, GARY W 29d
18178595 INTELLIGENT USER GUIDANCE FOR LABORATORY ISSUE RESOLUTION ANDERSON, FOLASHADE 36d
18017073 GDF-15 FOR PREDICTING THE DISEASE SEVERITY OF A PATIENT WITH COVID-19 ZOU, NIANXIANG 61d

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17891458 IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING MARCSISIN, ELLEN JEAN 51d overdue
18636375 METHODS AND SYSTEMS OF SAMPLE QUALITY VERIFICATION SANGHERA, STEVEN G.S. 38d overdue
18587217 COMPUTER-IMPLEMENTED METHOD WAQAS, SAAD A 19d overdue
17162140 Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure MARCSISIN, ELLEN JEAN 19d overdue
18561621 sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS COUNTS, GARY W 8d overdue
18649151 TRANSPORT DEVICE AND LABORATORY SAMPLE DISTRIBUTION SYSTEM JORGENSEN, ABBY A 3d overdue
18560126 METHOD FOR OPERATING A LABORATORY AUTOMATION SYSTEM, LABORATORY AUTOMATION SYSTEM, AND LABORATORY IN-VITRO DIAGNOSTIC SYSTEM BROTHERS, LAURENCE RAPHAEL 12d
17821951 TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION COUNTS, GARY W 13d

Top Art Units

Art UnitApps
1678 7
1758 3
1677 3
3651 2
3684 2
1796 2
1797 2
1798 2
1687 2
2884 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18649151 TRANSPORT DEVICE AND LABORATORY SAMPLE DISTRIBUTION SYSTEM JORGENSEN, ABBY A 3651 §102 Final Rejection 3d overdue Pending Apr 29, 2024
18636375 METHODS AND SYSTEMS OF SAMPLE QUALITY VERIFICATION SANGHERA, STEVEN G.S. 3684 §103 Final Rejection 38d overdue Pending Apr 16, 2024
18620273 LIGHT SOURCE FOR GENERATING ILLUMINATION LIGHT DOWNING, SAVANNAH STARR 2884 §103 Final Rejection 39d Pending Mar 28, 2024
18587217 COMPUTER-IMPLEMENTED METHOD WAQAS, SAAD A 2468 §102 Non-Final OA 19d overdue Pending Feb 26, 2024
18542054 THERMOSTABLE AFFINITY POLYPEPTIDES HAUK TEODORO, PRICILA NMN 1645 §112 Non-Final OA 57d Pending Dec 15, 2023
18561621 sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS COUNTS, GARY W 1678 §103 Non-Final OA 8d overdue Pending Nov 16, 2023
18560126 METHOD FOR OPERATING A LABORATORY AUTOMATION SYSTEM, LABORATORY AUTOMATION SYSTEM, AND LABORATORY IN-VITRO DIAGNOSTIC SYSTEM BROTHERS, LAURENCE RAPHAEL 3655 §103 Non-Final OA 12d Pending Nov 10, 2023
18557895 GDF15 MARKER PANELS FOR EARLY DETECTION OF SEPSIS MOAZZAMI, NAGHMEH NINA 1652 DPOther Non-Final OA 61d Pending Oct 27, 2023
18556849 INFORMATION PROCESSING DEVICE FOR PROVIDING REFERENCE INFORMATION RELATING TO DIAGNOSIS OF THYROID DISEASE HRANEK, KAREN AMANDA 3684 §103 Non-Final OA 25d overdue Pending Oct 23, 2023
18352183 PROGNOSTIC VALUE OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HAVING STABLE DISEASE SINES, BRIAN J 1796 §102 Non-Final OA 30d overdue Pending Jul 13, 2023
18338633 METHOD FOR PREPARING HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS LEAVITT, MORDECAI MIZANI 1742 Other Non-Final OA 56d Pending Jun 21, 2023
18337018 LC-MS METHOD FOR DETECTING AND QUANTIFYING 11-OXYGENATED STEROIDS SODERQUIST, ARLEN 1797 §103 Non-Final OA 21d Pending Jun 18, 2023
18333347 INTERFERENCE MONITORING FOR PROVIDING A VERIFIED ANALYTE MEASUREMENT HYUN, PAUL SANG HWA 1796 §103 Non-Final OA 33d Pending Jun 12, 2023
18312442 DERIVATIZATION OF AT LEAST ONE ANALYTE OF INTEREST FOR MASS SPEC MEASUREMENTS IN PATIENT SAMPLES XU, XIAOYUN 1797 §103 Non-Final OA 2d overdue Pending May 04, 2023
18309985 TIMP1 AS A MARKER FOR CHOLANGIOCARCINOMA DENT, ALANA HARRIS 1643 §102 Non-Final OA 20d Pending May 01, 2023
18308847 MONITORING DEVICE FOR MONITORING AN ELECTRIC MOTOR IN A LABORATORY SYSTEM TIMILSINA, SHARAD 2857 §112 Non-Final OA 118d overdue Pending Apr 28, 2023
18306195 DETECTION OF AN ANALYTE OF INTEREST BY NANOESI MASS SPECTROMETRY FRITCHMAN, REBECCA M 1758 §103 Final Rejection 21d Pending Apr 24, 2023
18296040 METHOD AND SYSTEM FOR DIAGNOSTIC ANALYZING ERICKSON, BENNETT S 3683 §103 Non-Final OA 60d overdue Pending Apr 05, 2023
18178595 INTELLIGENT USER GUIDANCE FOR LABORATORY ISSUE RESOLUTION ANDERSON, FOLASHADE 3623 §101 Non-Final OA 36d Pending Mar 06, 2023
18017073 GDF-15 FOR PREDICTING THE DISEASE SEVERITY OF A PATIENT WITH COVID-19 ZOU, NIANXIANG 1671 §101 Non-Final OA 61d Pending Jan 19, 2023
18149810 METHOD AND LABORATORY SYSTEM TO PROVIDE CONTROL SAMPLES FOR VALIDATING A DIAGNOSTICS TEST MCGUIRK, JOHN SCHUYLER 1798 §101 Final Rejection 8d overdue Pending Jan 04, 2023
17916251 A METHOD OF ASSESSING A FEMALE'S RISK OF HAVING PCOS AS WELL AS PRODUCTS AND USES RELATING THERETO VOLKOV, ALEXANDER ALEXANDROVIC 1677 §103 Non-Final OA 4d overdue Pending Sep 30, 2022
17907039 CORONA NUCLEOCAPSID ANTIGEN FOR USE IN ANTIBODY-IMMUNOASSAYS JOHANSEN, PETER N. 1644 §103 Non-Final OA 8d Pending Sep 22, 2022
17931993 CARRY-OVER MONITORING HILL, GRACELYN MARKHAM 1685 §103 Non-Final OA 13d Pending Sep 14, 2022
17821951 TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION COUNTS, GARY W 1678 §112 Final Rejection 13d Pending Aug 24, 2022
17891458 IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING MARCSISIN, ELLEN JEAN 1677 §103 Non-Final OA 51d overdue Pending Aug 19, 2022
17878282 MASKING OF LABORATORY DEVICES AND ROUTING OF TEST SAMPLE CONTAINERS IN A LABORATORY SYSTEM MINOR, AYANNA YVETTE 3624 §103 Final Rejection 42d overdue Pending Aug 01, 2022
17814332 SAMPLE INPUT INTERFACE CHIU, MAY LEUNG 1758 §102 Non-Final OA 54d Pending Jul 22, 2022
17792215 AUTOMATIC ANALYZER THOMPSON, CURTIS A 1798 §103 Final Rejection 20d Pending Jul 12, 2022
17838568 PARTICLE-BASED IMMUNOASSAY USING A PEGYLATED ANALYTE-SPECIFIC BINDING AGENT NGUYEN, NAM P 1678 §103 Non-Final OA 34d Pending Jun 13, 2022
17804947 AUTOMATED METHOD FOR HANDLING AN IN-VITRO DIAGNOSTICS CONTAINER IN AN IN-VITRO DIAGNOSTICS LABORATORY HERBERT, MADISON TAYLOR 1758 §103 Non-Final OA 110d overdue Pending Jun 01, 2022
17664230 METHOD AND DISTRIBUTION SYSTEM TO MOVE CARRIERS ON A TRANSPORT PLANE CUMBESS, YOLANDA RENEE 3651 §103 Non-Final OA 36d Pending May 20, 2022
17772959 SEPSIS MANAGEMENT COUNTS, GARY W 1678 §101 Non-Final OA 29d Pending Apr 28, 2022
17575120 S100A9 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS IVICH, FERNANDO NMN 1678 §101 Final Rejection 19d overdue Pending Jan 13, 2022
17575202 S100A12 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS MONTGOMERY, ANN Y 1678 §101 Non-Final OA 28d Pending Jan 13, 2022
17643559 SENSOR DEVICE AND METHOD OF USE WOITACH, JOSEPH T 1687 §103 Final Rejection 70d overdue Pending Dec 09, 2021
17447844 METHOD FOR DETERMINING AT LEAST ONE STATE OF AT LEAST ONE CAVITY OF A TRANSPORT INTERFACE CONFIGURED FOR TRANSPORTING SAMPLE TUBES SKIBINSKY, ANNA 1635 §103 Final Rejection 16d Pending Sep 16, 2021
17360121 DETECTION OF BACTERIAL (MOLLICUTIES) CONTAMINATION BERTAGNA, ANGELA MARIE 1681 §103 Non-Final OA 14d Pending Jun 28, 2021
17186163 THYMIDINE KINASE (TK-1) IN PROGNOSTIC INDICES FOR DLBCL PULLIAM, JOSEPH CONSTANTINE 1687 §103 Final Rejection 56d overdue Pending Feb 26, 2021
17162140 Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure MARCSISIN, ELLEN JEAN 1677 §112 Non-Final OA 19d overdue Pending Jan 29, 2021
17126439 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES ANGELL, JON E 1637 §102 Final Rejection 16d Pending Dec 18, 2020
16008281 FKBP DOMAIN WITH TRANSGLUTAMINASE RECOGNITION SITE DABKOWSKI, ERINNE R 1654 §112 Non-Final OA 42d overdue Pending Jun 14, 2018
15892829 ALKALINE PRETREATMENT OF PARVOVIRUSES FOR IMMUNOASSAYS NGUYEN, NAM P 1678 §103 Final Rejection 26d Pending Feb 09, 2018

Managing Roche Diagnostics Operations Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month